Ledger.Open graph →
SEC Form D · filed March 11, 2024

Crinetics Pharmaceuticals, Inc

Offering
$350.0M
Sold
$350.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Matthew S. Fust · SAN DIEGO, CADirectorCaren S. Deardorf · SAN DIEGO, CADirectorStephanie S. Okey · SAN DIEGO, CADirectorJames V. Hassard · SAN DIEGO, CAExecStephen V. Betz · SAN DIEGO, CAExecRogerio V. Coelho, M.D · SAN DIEGO, CADirectorWeston S. Nichols, Phd · SAN DIEGO, CADirectorMarc S. Wilson · San Diego, CAExecCamille S. Bedrosian, M.D · SAN DIEGO, CADirectorRichard S. Struthers, Phd · SAN DIEGO, CAExec · DirectorJeff V. Knight · SAN DIEGO, CAExecWendell S. Wierenga, Phd · SAN DIEGO, CADirectorDana V. Pizzuti · SAN DIEGO, CAExecJames V. Hassard · SAN DIEGO, CAExecStephen V. Betz · SAN DIEGO, CAExecRogerio V. Coelho, M.D · SAN DIEGO, CADirectorWeston S. Nichols, Phd · SAN DIEGO, CADirectorMarc S. Wilson · San Diego, CAExecCamille S. Bedrosian, M.D · SAN DIEGO, CADirectorMatthew S. Fust · SAN DIEGO, CADirectorRichard S. Struthers, Phd · SAN DIEGO, CAExec · DirectorJeff V. Knight · SAN DIEGO, CAExecWendell S. Wierenga, Phd · SAN DIEGO, CADirectorDana V. Pizzuti · SAN DIEGO, CAExecCaren S. Deardorf · SAN DIEGO, CADirectorStephanie S. Okey · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗